RECRUITING

Adapting the Tumor Board Model for Mental Illness and Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study examines the feasibility and acceptability of a virtual tumor board for cancer and mental illness for patients with serious mental illness and a new cancer diagnosis. The study also examines the impact on patient care, psychiatric symptoms, and clinician self-efficacy in managing this population.

Official Title

Adapting the Tumor Board Model for Mental Illness and Cancer: A Single Arm Pilot Trial

Quick Facts

Study Start:2023-05-31
Study Completion:2024-05-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05837598

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age ≥ 18 years old
  2. 2. Verbal fluency in English
  3. 3. SMI (schizophrenia spectrum disorder, bipolar disorder, or major depressive disorder with either prior psychiatric hospitalization, history of suicide attempt/suicidal ideation, Medicaid insurance, and/or comorbid alcohol or opioid use disorder) confirmed by diagnostic evaluation of study psychiatrist
  4. 4. New invasive stage I-IV breast, lung, gastrointestinal, genitourinary, or head and neck cancer (highly suspected or confirmed according to documentation by the oncologist or pathology)
  5. 5. Oncology consultation at or referral to a MGH Danvers within the past 8 weeks
  1. 1. Have cognitive impairment severe enough to interfere with completing brief study assessments or providing informed consent and does not have a guardian who can provide consent
  2. 2. Recurrence of same cancer type
  3. 3. Do not have verbal fluency in English

Contacts and Locations

Study Contact

Kelly Irwin, MD, MPH
CONTACT
617-643-4453
kirwin1@partners.org

Study Locations (Sites)

Mass General/North Shore Center for Outpatient Care
Danvers, Massachusetts, 01923
United States

Collaborators and Investigators

Sponsor: Massachusetts General Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-05-31
Study Completion Date2024-05-31

Study Record Updates

Study Start Date2023-05-31
Study Completion Date2024-05-31

Terms related to this study

Keywords Provided by Researchers

  • Cancer Care
  • Major Depression and Cancer
  • Schizophrenia and Cancer
  • Bipolar disorder and Cancer
  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancer
  • Gastrointestinal Cancer
  • Genitourinary Cancer
  • Schizophrenia
  • Bipolar Disorder
  • Major Depression
  • Health equity
  • Mental disorders

Additional Relevant MeSH Terms

  • Cancer
  • Severe Major Depression
  • Schizophrenia
  • Bipolar Disorder
  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancer
  • Gastrointestinal Cancer
  • Genitourinary Cancer